Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Neal S. Akhave et al.|Cancer Discovery|2023Cited by 181
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective studyMaliazurina B. Saad, Jia Wu, Lingzhi Hong et al.|The Lancet Digital Health|2023Cited by 108